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1. INTRODUCTION 2. EXPERIMENTAL 
Human fibrinogen is a phosphoprotein with part 
of the phosphorus bound to Iibrinopeptide A [ 1,2]. 
However, most of the phosphorous remains bound 
to the fibrin after splitting off the tibrinopeptides 
121. Phosphorylserine occurs at 2 or more locations 
in the a-chain 131, one of which is SerMl [4]. It was 
recently found that human fibrinogen is a substrate 
of cyclic AMP-stimulated protein kinase in vitro 
with a maximal incorporation of z 6 mol phos- 
phate/mol fibrinogen, preferentially into the 
a-chain [5]. One of the phosphate-accepting sites is 
Ser44t of the a-chain [5]. 
2.1. Materials 
[32P]ATP was purchased from New England 
Nuclear (Boston MA). Human fibrinogen was ob- 
tained from Kabi AB (Stockholm). Mixed histone 
(type II-AS), protamine (salmon sperm), phosvitin, 
1,2-diolein and phosphatidylserine were products 
of Sigma. Sephadex was purchased from Pharmacia 
Fine Chemicals (Uppsala). The DEAE-cellulose 
and the phosphorylcellulose used were Whatman 
DE-52 and P- 11, respectively. 
2.2. Enzyme assays 
Most phosphate bound to serine and threonine 
residues in proteins appears to have regulatory 
functions and is incorporated in protein kinase 
reactions. As one approach to study the physiologi- 
cal role of fibrinogen phosphate it was of interest to 
look for more protein kinases active on fibrinogen. 
Therefore, extracts from different rat tissues were 
incubated with [32P]ATP and human fibrinogen. It 
was found that brain and spleen contain a high 
fibrinogen kinase activity which was not stimulated 
by cyclic AMP. After a partial purification from 
brain tissue it was demonstrated that the main part 
of the enzyme activity was stimulated by Ca2+, 
phosphatidylserine and diolein in a similar manner 
as the protein kinase described in [6]. Some of the 
methods in ]7] were used to obtain a calcium-acti- 
vated, phospholipid-dependent protein kinase from 
rat brain. Human fibrinogen is shown to be a good 
substrate for this protein kinase preparation. 
Protamine kinase and histone kinase activities 
were assayed as in [8] using 75 ~1 final incubation 
vol. Phosvitin kinase activity was estimated under 
the same conditions. This was also the case for lib- 
rinogen kinase determinations except that 2 mg 
fibrinogen/ml and 0.1 mM [32P]ATP were used. 
When the effects of Ca2+, phosphatidylserine and 
diolein were investigated mercaptoethanol was 
omitted. Fibrinogen was dialyzed against 50 mM 
potassium phosphate buffer (pH 7.5) before use. 
The s ecific radioactivity of the [32P]ATP was - 4 
x ! 10 cpm/nmol. Phosphatidylserine and diolein 
were dissolved separately in chloroform/methanol 
(95/5, v/v) to 10 mg/ml and 5 mg/ml, respectively. 
Phosphatidylserine (15 ~1) and diolein (2.4 ~1) solu- 
tions were emulsified for 15 min at 0°C with 1.98 ml 
20 mM Tri-HCl (pH 7.5) with an MSE 150 Watt 
Ultrasonic Disintegrator. When added to the pro- 
tein kinase assay, final cont. was 10 pg/ml and 0.8 
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pg/ml, respectively. One unit of protein kinase act- 
ivity was defined as that amount which incorporated 
1 pmol phosphate from [32P]ATP to acid-precip- 
itable proteimmin under the conditions used. 
2.3. Analytical methods 
One-dimensional polyacrylamide gel electro- 
phoresis was performed using the slab gel system [9] 
modified [lo]. [32P]Phosphorylserine and 
(a3szPjphosphorylthreonine were isolated from acid 
hydrolysates of 32P-labelled fibrinogen by chroma- 
tography on Dowex 50-X8 and Dowex-l-X8 as in 
1111. 
2.4. Preparation of tissue extracts for estimation of 
fibrinogen kinase and histone kinase 
Brain, spleen and liver tissue was rapidly re- 
moved from decapitated Sprague-Dawley rats 
(300 g body wt) and homogenized in a Potter- 
Elvehjem Teflon-glass homogenizer as in [7] with 
4 vol. 20 mM Tris-HCl buffer (pH 7.5) containing 
0.25 M suciose, 2 mM EDTA and 10 mM EGTA. 
Muscle tissue was homogenized with 4 vol. of the 
same buffer using a Polytron homogenizer. The 
homogenates were centrifuged at 0-4°C and 
80 000 x g for 90 min. The supernatants were 
chromatographed on Sephadex G-50 columns 
which were equilibrated with 20 mM Tris-HCl 
buffer (pH 7.5) also containing 1 mM EDTA, 50 
mM mercaptoethanol and 10% glycerol. The vol- 
ume of the samples applied was maximally - 15% of 
the volume of the column. Fractions corresponding 
to the void volume were pooled and assayed for 
protein kinase activity with fibrinogen or histone as 
substrate. 
2.5. Purification of calcium-activated, phospholipid- 
dependent protein kinase 
Calcium-activated, phospholipid - dependent pro- 
tein kinase of rat brain was prepared according 
to the initial steps~ in [7]. To dissociate the holo- 
enzyme of cyclic AMP-stimulated protein kinase in- 
to its catalytic and regulatory subunits, cyclic AMP 
was added to the supernatant from 12 rat brains 
( - 2 1 g wet wt) to 10 ~1 final cont. The supernatant 
was immediately applied to a 2.2 X 10 cm DE-52 
column in equilibrium with 20 mM Tris-HCl (pH 
7.5) also containing 10 PM cyclic AMP, 50 mM 
mercaptoethanol, 5 mM EGTA and 2 mM EDTA. 
The column was eluted with 500 ml of the starting 
200 
buffer, followed by a linear gradient of 300 ml 
starting buffer and 300 ml same buffer, containing 
0.4 M NaCl. The eluted fractions were assayed for 
fibrinogen, protamine, histone and phosvitin kinase 
activities. Two peaks of fibrinogen kinase activity 
were obtained (fig. 1). The material of the two peaks 
were pooled separately and concentrated using 
Amicon PM 10 filters followed by collodion bags 
(Sartorius-Membrane Filter, Gottingen). The 
material from the first fibrinogen kinase peak 
(pool I) was then chromatographed on a 1.6 x 60 
cm Sephadex G-200 column equilibrated with 20 
mM Tris-HCl buffer (pH 7.5) 0.5 mM EGTA and 
50 mM mercaptoethanol (fig. 2). 
The material from the second fibrinogen kinase 
peak (pool II) was chromatographed on a 5.3 x 44 
cm Sephadex G-50 column equilibrated with 
20 mM Tris-HCl (pH 7.5) also containing 1 mM 
EDTA, 50 mM mercaptoethanol and 10% glycerol. 
The void volume was then applied to a 1.5 x 12 cm 
phosphocellulose column equilibrated and eluted 
with the same buffer. Most of the fibrinogen kinase 
activity was not retarded. The flow-through fraction 
was then concentrated and chromatographed on a 
Sephadex G-200 column (fig. 3) as described above 
for the enzyme from the first fibrinogen kinase peak 
from the DE-52 column. 
3. RESULTS 
3.1. Tissue distribution ofjbrinogen kinase activity 
It was shown that extracts from brain and spleen 
contained a considerable fibrinogen kinase activity 
in the absence of cyclic AMP while the extracts 
from liver and muscle had a much lower activity 
(table 1). When extracts from various tissues were 
compared, it was found that the fibrinogen kinase 
activity had a different distribution than the histone 
kinase activity. This was even more pronounced 
when the protein kinase activity was tested in the 
presence of cyclic AMP. While the histone kinase 
activity varied between different organs within a 
factor of - 2, there was a 30-fold variation between 
the extracts with regard to fibrinogen kinase activ- 
ity. From table 1 it is obvious that the extracts from 
brain and spleen contained fibrinogen kinase activ- 
ity which was not due to cyclic AMP-stimulated 
protein kinase. In addition, some of the phospho- 
rylation of fibrinogen was dependent on cyclic 
AMP-stimulated protein kinase, since cyclic AMP 
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Table 1 
Fibrinogen kinase and histone kinase activities in extracts 
from different rat organs 
Fibrogen kinase Histone kinase 
(units/g tissue) (units/g tissue) 
- CAMP + cAmp - CAMP + CAMP 
Brain 3080 3380 3800 7110 
Spleen 1580 1510 1850 5790 
Liver 120 110 290 3320 
Muscle 280 470 1520 7230 
Cell sap. prepared as in section 2, was applied to Sepha- 
dex G-50 columns equilibrated with 20 mM Tris-HCl 
(PH 7.5)-l@% glycerol-l mM EDTA-50 mM mercap- 
toethanol. Protein kinase activity was assayed as in sec- 
tion 2 with 2 mg fibrinogen/ml or 0.4 mg mixed histone 
/ml, 0.1 mM (32P]ATP and 5 mM magnesium acetate. 
Cyclic AMP was 4 PM when present. 
stimulated the phosphorylation slightly with an ex- 
tract from brain and considerably with an extract 
from muscle. 
3.2. Copurljication from rat brain of calcium- 
activated, phospholipid-dependent protein kin- 
ase andfibrinogen kinase 
Brain and spleen, which were shown here to have 
a high fibrinogen kinase activity (table l), are also 
known to contain a large amount of calcium- 
activated, phospholipid-dependent protein kinase 
112,131. Due to the high activity of this protein kin- 
ase in thrombocytes [ 121 and since calcium and 
phospholipid are essential in blood coagulation, it 
seemed to be an interesting possibility that fibrino- 
gen is a substrate of calcium-activated, phospho- 
lipid-dependent protein kinase. Therefore, the pro- 
tein kinase was partially purified from rat brain 
according to the initial steps in [7], using protamine 
and histone as substrates. In addition, the fractions 
were assayed for fibrinogen kinase activity to see 
whether the kinase activities copurify in the chro- 
matographic systems and whether they have other 
properties in common. 
Fibrinogen kinase activity was eluted from a 
DE-52 column as one minor and one major broad 
peak together with protamine and histone kinase 
activity (fig. 1). According to 171, the main protamine 
kinase peak should represent the calcium-activated, 
phospholipid-dependent protein kinase [ 141. The 
large phosvitin kinase peak was eluted somewhat 
later than the second fibrinogen kinase peak. This 
general pattern was very reproducible. To remove 
most of the phosvitin kinase activity the material 
from the second fibrinogen kinase peak was filtered 
through a phosphorylcellulose column as in section 
2. The main part of the fibrinogen kinase activity 
which was not retained on the phosphorylcellulose 
column, as well as the material of the first fibrino- 
gen kinase peak from the DE-52 column, were 
concentrated separately to - 2.5 ml and each sam- 
ple applied to a Sephadex G-200 column. 
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Fig.1. Chromatography of cell sap from rat brain on a 
DE-52 column: A,B describe the same chromatogram. 
Protein kinase activity estimated with different substrates 
as in section 2: (A) (-) absorbance at 280 nm, (A-A) 
protamine kinase activity, (A-A) phosvitin kinase acti- 
vity; (B) (O-O) fibrinogen kinase activity, (e-0) his- 
tone kinase activity, (- - -) [NaCl]; fractions pooled as 
indicated &II). 
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Fig.2. Chromatography of pool I of fibrinogen kinase 
from DE-52 chromatography in fig.1 on a Sephadex 
G-200 column, as in section 2: (A) symbols as in fig. 1; (B) 
(O---O), (O-O) fibrinogen kinase activity in the presence 
and absence, respectively, of Ca2+, phosphatidylserine 
and diolein; (o---o), (O-O), histone kinase activity in the 
presence and absence, respectively, of Ca2+, phosphati- 
dylserine and diolein. Ca*+ was 0.5 mM when present. 
Fig2A demonstrates a typical Sephadex G-200 
chromatogram of material from the first fibrinogen 
kinase peak from a DE-52 chromatography. The 
fibrinogen kinase activity was eluted as one main 
peak preceded by a minor peak. Histone and pro- 
tamine kinase activity were eluted roughtly in 
parallel with the fibrinogen kinase activity. The main 
peak appeared after - 0.6 column volume. When 
the fibrinogen kinase activity was assayed in the 
presence of 0.5 mM CaCl, phosphatidylserine and 
diolein there was - 5-fold stimulation whereas the 
activity on mixed histone showed - 2-fold stimu- 
lation (fig.ZB). With other enzyme preparations 
there was only a 2-fold stimulation of the basal 
fibrinogen kinase activity and almost no stimula- 
tion of the histone kinase activity. 
A similar Sephadex G-200 chromatogram was 
obtained with the material from the second fibrin- 
ogen kinase peak eluted from the DE-52 column 
(fig.3A). While the stimulation of the fibrinogen 
kinase activity with Ca*+ and lipids was consider- 
able, there was hardly any stimulation of the 
phosphorylation of mixed histone. In some prepar- 
ations, there was up to 2-fold stimulation of the 
histone kinase activity. 
3.3. Effect of Ca2 ’ , phosphatidylserine and diolein 
on the fibrinogen kinase activity 
The fibrinogen kinase peaks eluted from Sepha- 
dex G-200 (fig. 2B,3B) were stimulated by a mixture 
of Ca*+. phosphatidylserine and diolein, indicating 
that the enzyme activity was of the same type as in 
[7,14]. To confirm this idea the effect of each lipid 
component was studied by activity measurements 
on both enzyme pools with omission of one com- 
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Fig.3. Chromatography of pool II of fibrinogen kinase 
from DE-52 chromatography in fig.1 on a Sephadex 
G-200 column, as in section 2: (A),(B) symbols as in fig.2. 
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Table 2 
Effect of Ca2+, phosphatidylserine and diolein on the 
fibrinogen kinase activity 
Incubation 
conditions 
Relative enzyme 
activity 
Pool I 
Control: 
-Cal+, 
- phosphatidylserine, 
- diolein I 
A: 10 PM Ca2+ 
Complete 
- phosphatidylserine 
- diolein 
B: 500 PM Ca2+ 
Complete 
- phosphatidylserine 
- diolein 
100 
142 344 
102 182 
120 214 
183 627 
96 167 
179 435 
Pool II 
loo 
Pools I and II from the DE-52 chromatography were 
purified on Sephadex G-200 chromatographies (as 
shown in fig.2 and 3, respectively) and dialyzed against 
20 mM Tris-HCl (pH 7.5)-0.03 mM EGTA-50 mM 
mercaptoethanol before use. The complete assay 
systems contained 10 pg phosphatidylserine/ml, 0.8 pg 
diolein/ml and 10 or 500 PM Ca2+. 
ponent at a time at two different [Ca*+]. The acti- 
vity of both enzyme pools was decreased when 
either phosphatidylserine or diolein was omitted 
(table 2). The only exception was that diolein did 
not have any effect on the activity of pool I at 500 
PM Ca2+. The activity increased considerably 
when [Ca*+] was increased from lo-500 PM. 
Thus, Ca*+ , phosphatidylserine and diolein have 
each been shown to be activators of the fibrinogen 
kinase activity. 
3.4. Phosphorylation site(s) infibrinogen 
Since the phosphate of fibrinogen is located to 
the a-chain [3] one would expect that the enzyme 
from pools I and II should incorporate labelled 
phosphate from [32P]ATP into this chain if the en- 
zyme reactions were to have a physiological signi- 
ficance. Therefore, fibrinogen was separately 
‘*P-labelled with both enzyme pools after chroma- 
tography on Sephadex G-200 and analyzed by 
polyacrylamide gel electrophoresis in sodium lauryl 
sulphate under reducting conditions followed by 
autoradiography. In both cases nearly all the 
radioactivity was associated with the a-chains (not 
shown). 
From acid hydrolysates of 32P-labelled fibrin- 
ogen, [32P]phosphorylserine and traces of [32P]phos- 
phorylthreonine were isolated by Dowex 50-X8 and 
Dowex l-X8 chromatography. Thus, serine residues 
seem to be preferentially phosphorylated. 
4. DISCUSSION 
A fibrinogen kinase activity has been found and 
partially purified from rat brain. The enzyme is 
stimulated by Ca*+, phosphatidylserine and diol- 
ein. It is eluted in a similar position to the protein 
kinase of Nishizuka on DE-52 and Sephadex G-200 
chromatographies. It is heterogenous on these 
chromatographies, as also described for the enzyme 
in 171. The distribution of the fibrinogen kinase 
between some organs (table 1) is about the same as 
for the calcium-activated, phospholipid-dependent 
protein kinase [ 12,131. Even though the fibrinogen 
kinase has not been purified and characterized ex- 
tensively, it is obvious that it is of the same type as 
the protein kinase found by Nishizuka’s group. 
All the phosphorus of fibrinogen seems to be 
present in the a-chain [3,4]. This subunit is phos- 
phorylated by the cyclic AMP-stimulated protein 
kinase [S] and, in addition, the protein kinase stud- 
ied here phosphorylated the a-chain of fibrinogen. 
It should be pointed out that it is quite usual for a 
protein to serve as a substrate for > 1 protein kin- 
ase. Examples are phosphorylase kinase and gly- 
cogen synthase, which are also substrates of the 
calcium-activated, phospholipid-dependent protein 
kinase [ 141. 
Due to the essential roles of platelets and fibrin- 
ogen in blood coagulation it is interesting that the 
highest activity of this enzyme has been reported for 
platelets [ 121 and that the enzyme might be involved 
in platelet activation [ 151. 
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